KRMD
Koru Medical Systems Stock Analysis
AI Rating
- Quality2/10
- Growth↑ 7/10
- Value↓ 1/10
KRMD Growth
- Revenue Y/Y↑ 22.23%
- EPS Y/Y↑ 53.85%
- FCF Y/Y↑ 71.19%
KRMD Profitability
- Gross margin ↑ 62.30%
- EPS margin↓ -6.40%
- ROIC 5Y↓ -37.54%
KRMD Risk
- Debt / Equity↓ 0.2
- Debt / FCF↓ 0.0
- Interest coverage↑ 999.0
Koru Medical Systems stock volatility is in-line with the overall market. We give it a Great risk rating.